Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. The company engages in identifying small molecules that inhibit or express NR2F6, leading to immune cell activation for oncology applications and immune cell suppression for autoimmune disease... Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. The company engages in identifying small molecules that inhibit or express NR2F6, leading to immune cell activation for oncology applications and immune cell suppression for autoimmune diseases. It also develops several products: HemaXellarate, a cellular therapeutic product derived from autologous stromal vascular fraction from adipose tissue; dCellVax, an autologous dendritic cell treated with an siRNA inhibitor of indoleamine-2,3-dioxygenase; tCellVax, which is treated with siRNA to inhibit NR2F6, with the cells re-infused into the patient; DiffronC, which uses proprietary siRNA in vivo to inhibit cancer growth and activate T cells; and DuraCAR, comprising CAR-T cells treated with an shRNA targeting the gene NR2F6. Regen BioPharma was incorporated in 2012 and is based in La Mesa, California. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0002 | -66.6666666667 | 0.0003 | 0.0003 | 0.0001 | 59984485 | 0.00017838 | CS |
| 4 | -0.0003 | -75 | 0.0004 | 0.0005 | 0.0001 | 30728972 | 0.0002561 | CS |
| 12 | -0.0005 | -83.3333333333 | 0.0006 | 0.0009 | 0.0001 | 18262280 | 0.00036408 | CS |
| 26 | -0.0088 | -98.8764044944 | 0.0089 | 0.0114 | 0.0001 | 11819099 | 0.00069104 | CS |
| 52 | -0.0439 | -99.7727272727 | 0.044 | 0.1169 | 0.0001 | 6128702 | 0.00143487 | CS |
| 156 | -1.6799 | -99.994047619 | 1.68 | 2.15 | 0.0001 | 2066927 | 0.00434447 | CS |
| 260 | -0.0238 | -99.5815899582 | 0.0239 | 2.615 | 0.0001 | 18143009 | 0.01960485 | CS |
FDA-agent-1
3日前
02opida
2週前
02opida
3週前
Pikegold87
1月前
SanDiegoAlan
2月前
Wallstreeter$$$
2月前
gotinearly
4月前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。